Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer.
Ye L, Lin C, Wang X, Li Q, Li Y, Wang M, Zhao Z, Wu X, Shi D, Xiao Y, Ren L, Jian Y, Yang M, Ou R, Deng G, Ouyang Y, Chen X, Li J, Song L.
Ye L, et al. Among authors: ren l.
EMBO Mol Med. 2022 Mar 7;14(3):e15618. doi: 10.15252/emmm.202115618.
EMBO Mol Med. 2022.
PMID: 35253379
Free PMC article.
No abstract available.